ARGENT ADVISORS, INC. – Eli Lilly and Company Transaction History
ARGENT ADVISORS, INC. portfolio value:
$1.46M
portfolio value
ARGENT ADVISORS, INC. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -4K | $323.35 | 4.53K | |
| Q2 2022 | share | 0.00% | 0 shares | 171K | $324.23 | 4.53K | |
| Q1 2022 | share | 0.00% | 0 shares | 46K | $286.37 | 4.53K | |
| Q4 2021 | share | 0.00% | 0 shares | 205K | $277.25 | 4.53K | |
| Q3 2021 | share | Decrease | -2.37% | -110 shares | -18K | $230.3 | 4.53K |
| Q2 2021 | share | Decrease | -4.03% | -195 shares | 162K | $228.04 | 4.64K |
| Q1 2021 | share | Increase | +67.16% | 1.94K shares | 415K | $184.81 | 4.83K |
| Q4 2020 | share | Decrease | -33.71% | -1.47K shares | -158K | $166.32 | 2.89K |
| Q3 2020 | share | Decrease | -1.36% | -60 shares | -80K | $145.05 | 4.36K |
| Q2 2020 | share | Decrease | -3.22% | -147 shares | 92K | $160.1 | 4.42K |
| Q1 2020 | share | Decrease | -0.65% | -30 shares | -14K | $134.64 | 4.57K |
| Q4 2019 | share | Increase | 0.00% | 4.60K shares | 648K | $126.91 | 4.60K |